Innovating Men's Well-Being Through Testosterone Research

Join us for an exclusive investor webinar where Acesis Biomed will present its vision for the future of testosterone therapy.

REGISTER NOW →

April 17th at 11:00AM PST

Innovating Men's Health Through Testosterone Research

Join us for an exclusive investor webinar where Acesis Biomed will present its vision for the future of testosterone therapy.

REGISTER NOW →

April 17th at 11:00AM PT

Our leadership team will walk through the investment opportunity, highlighting the urgent need for innovation in hormone health and how our non-steroidal, oral therapy is positioned to disrupt the market.

Our leadership team will walk through the investment opportunity, highlighting the urgent need for innovation in hormone health and how our non-steroidal, oral therapy is positioned to disrupt the market.

“Product innovation is driving the testosterone therapy market with Acesis BioMed developing a non-steroidal oral peptide designed to naturally stimulate testosterone production, offering a potentially safer alternative to traditional treatments”

—

Naturally restoring testosterone
levels with potentially minimal side effects

The discoveries by Dr. Papadopoulos, a world-renowned expert in steroid biochemistry with 35+ years of experience, has resulted in a novel mechanism of action that restores the body’s natural ability to produce testosterone (based on our current preclinical data)—a breakthrough protected by two patent families owned by Acesis.

Naturally restoring testosterone
levels with potentially minimal side effects

The discoveries by Dr. Papadopoulos, a world-renowned expert in steroid biochemistry with 35+ years of experience, has resulted in a novel mechanism of action that restores the body’s natural ability to produce testosterone (based on our current preclinical data)—a breakthrough protected by two patent families owned by Acesis.

Register Now to Learn More About the Future of Testosterone Treatments

SAVE YOUR SPOT →

©2025 Acesis Biomed. All rights reserved.